Company: SLDE
Filing Date: 2025-01-22
Form Type: DRS/A
Source: 0000950123-25-000502
Chunk: 2

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-01-22
Form: DRS/A
Chunk 2
---
 sale is not permitted. SUBJECT TO COMPLETION, DATED , 2025 PRELIMINARY PROSPECTUS Shares Slide Insurance Holdings, Inc. Common Stock $ per share This is the initial public offering of common stock of Slide Insurance Holdings, Inc. (“Slide”). We are offering shares of our common stock. The selling stockholders identified in this prospectus, including certain of our directors and officers, are offering an additional shares of our common stock. Slide will not receive any proceeds from the sale of shares of our common stock by the selling stockholders. Prior to this offering, there has been no public market for our common stock. We anticipate that the initial public offering price of our common stock will be between $ and $ per share. We have applied to list our common stock on the Nasdaq Global Select Market (“Nasdaq”) under the symbol “SLDE.” Investing in our common stock involves risks. See “ Risk Factors ” beginning on page 16. We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act and will therefore be subject to reduced reporting requirements. See “ Prospectus Summary—Implications of Being an Emerging Growth Company.” Neither the Securities and Exchange Commission nor any state securities commission or regulatory authority has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                                      |     | Per Share |     | Total |
|:-----------------------------------------------------|:----|:----------|:----|:------|
| Initial public offering price                        |     | $         |     | $     |
| Underwriting discounts and commissions               |     | $         |     | $     |
| Proceeds to Slide before expenses(1)                 |     | $         |     | $     |
| Proceeds to the selling stockholders before expenses |     | $         |     | $     |

| (1) | We have agreed to reimburse the underwriters for certain FINRA-related expenses. See 
 “Underwriting.”                                                                      |

The selling stockholders have granted the underwriters the right to purchase an additional shares of common stock to cover over-allotments. At our request, the underwriters have reserved up to 5% of the shares of common stock offered by this prospectus for sale, at the initial public offering price, to certain individuals associated with us and our stockholders. See “ Underwriting—Directed Share Program.” The underwriters expect to deliver the shares to purchasers on